Conformal Partial Breast Irradiation With CyberKnife After Resection for Early Stage Breast Cancer (CKPBI)
Sponsor: Essentia Health
A NA clinical study on Breast Cancer, this trial is completed. The trial is conducted by Essentia Health and has accumulated 12 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Nov 2024 — Sep 2025 [monthly]
Active Not Recruiting NA
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
▶ Show 7 earlier versions
-
Jun 2023 — Jun 2024 [monthly]
Active Not Recruiting NA
-
Jul 2022 — Jun 2023 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Jul 2022 [monthly]
Active Not Recruiting NA
-
Jan 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Nov 2018 — Jan 2020 [monthly]
Active Not Recruiting NA
Phase: PHASE1_PHASE2 → NA
-
Jun 2018 — Nov 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
First recorded
Jun 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Essentia Health
For direct contact, visit the study record on ClinicalTrials.gov .